View in EDS HTML Full Text PDF Full Text

STAT1-L351F is associated with enhanced interferon signaling and susceptibility to Talaromyces marneffei infection.

Saved in:
Bibliographic Details
Title: STAT1-L351F is associated with enhanced interferon signaling and susceptibility to Talaromyces marneffei infection.
Authors: Gu Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.; School of Medicine, Southern University of Science and Technology, Shenzhen, China., Zhang H; School of Public Health, Shenzhen University Medical School, Shenzhen, China., Lin Q; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Ye G; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China., Lian D; Hargen Biotechnology (Shenzhen) Co., Ltd, Shenzhen, China., Li X; School of Public Health, Shenzhen University Medical School, Shenzhen, China., Liu Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China., Yuan J; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China., Guo L; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Key Laboratory of Basic Research on Regional Diseases, Guangxi Medical University, Education Department of Guangxi Zhuang Autonomous Region, Nanning, China.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1813775. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42088517
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: STAT1-L351F is associated with enhanced interferon signaling and susceptibility to Talaromyces marneffei infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gu+Y%22">Gu Y</searchLink>; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.; School of Medicine, Southern University of Science and Technology, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; School of Public Health, Shenzhen University Medical School, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Lin+Q%22">Lin Q</searchLink>; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Ye+G%22">Ye G</searchLink>; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Lian+D%22">Lian D</searchLink>; Hargen Biotechnology (Shenzhen) Co., Ltd, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; School of Public Health, Shenzhen University Medical School, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Yuan+J%22">Yuan J</searchLink>; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Guo+L%22">Guo L</searchLink>; Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Key Laboratory of Basic Research on Regional Diseases, Guangxi Medical University, Education Department of Guangxi Zhuang Autonomous Region, Nanning, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1813775. <i>Date of Electronic Publication: </i>2026 Apr 20 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42088517
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1813775
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1813775
    Titles:
      – TitleFull: STAT1-L351F is associated with enhanced interferon signaling and susceptibility to Talaromyces marneffei infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gu Y
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Lin Q
      – PersonEntity:
          Name:
            NameFull: Ye G
      – PersonEntity:
          Name:
            NameFull: Lian D
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Yuan J
      – PersonEntity:
          Name:
            NameFull: Guo L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 04
              Text: 2026 Apr 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1